Nexstim is a medical device company developing “NBS”–a noninvasive;image-guided TMS for brain diagnostics and therapy.
Nexstim has raised €16M across 3 funding rounds from 2 investors, most recently a round in Dec 2014. Based in Helsinki, Finland; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2014-12-01 | Other | €3.4M | — | View deal → |
| 2011-05-01 | Other | €2.0M | Capricorn Venture Partners | View deal → |
| 2011-01-01 | Other | €11M | Life Sciences Partners | View deal → |
